| Marley Dutcher, MS, CCC-SLP | |
|
13 Vincent Way, Cumberland, RI 02864-2846 | |
| (401) 225-7728 | |
| Not Available |
| Full Name | Marley Dutcher |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 13 Vincent Way, Cumberland, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114313178 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 9963 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marley Dutcher, MS, CCC-SLP 122 Grove St, Franklin, MA 02038-2180 Ph: (949) 397-0303 | Marley Dutcher, MS, CCC-SLP 13 Vincent Way, Cumberland, RI 02864-2846 Ph: (401) 225-7728 |
News Archive
UT Dallas researchers recently demonstrated how nerve stimulation paired with specific experiences, such as movements or sounds, can reorganize the brain. This technology could lead to new treatments for stroke, tinnitus, autism and other disorders.
New Weizmann Institute research may bring the idea of sleep learning one step closer to reality. The research, which appeared today in The Journal of Neuroscience, suggests that certain kinds of conditioning applied during sleep could induce us to change our behavior. The researchers exposed smokers to pairs of smells - cigarettes together with that of rotten eggs or fish - as the subjects slept, and then asked them to record how many cigarettes they smoked in the following week.
Virtual reality goggles that immerse patients in scenes of beauty that can help manage pain and anxiety. A new type of laryngoscope that increases the speed and safety of intubation.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today presented an analysis of baseline data from the Phase 3 DEFEND-1 clinical trial of otelixizumab in patients with autoimmune new onset type 1 diabetes.
Enigma Diagnostics Limited, the decentralised point-of-care molecular diagnostics company, announces the showcasing of its fully automated Point-of-Care mini-laboratory instrument, the Enigma ML, at MEDICA 2009 at the Dusseldorf Trade Fair Centrehas in Dusseldorf, Germany in Hall 1, stand E07a between 18-20 November.
› Verified 3 days ago
Ms. Cheryl A Webster, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Tallyho Rd, Cumberland, RI 02864 Phone: 401-743-1554 | |
Miss Katherine Herbert, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15 Sumner Brown Rd, Cumberland, RI 02864 Phone: 401-333-6352 | |
Brooke Mackenzie Taylor, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Martin St Ste 4b, Cumberland, RI 02864 Phone: 401-228-2186 | |
Valentina Karnaukh, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15 Summer Brown Road, Cumberland, RI 02864 Phone: 401-333-6352 | |
Briana Therien, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Chambers St, Cumberland, RI 02864 Phone: 401-724-7500 | |
Ms. Dawn Elaine Macmeans, MA CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 15 Sumner Brown Rd, Cumberland, RI 02864 Phone: 401-333-6352 Fax: 401-333-1012 |